S2G Ventures, a leading multi-stage investment firm focused on the food, agriculture, ocean and seafood markets, has invested in five companies across four countries as part of its inaugural investment in oceans and seafood, including Israel's ViAqua, the venture company announced this week.
Follow Israel Hayom on Facebook and Twitter
These investments are aligned with S2G's commitment to supporting leading entrepreneurs in the blue economy who are building scalable solutions for a more sustainable and resilient ecosystem.
Founded in 2014 by Shai Ufaz and Shai Einbinder and based in Israel, ViAqua is a biotechnology producer of an orally administered particle-based platform for the delivery of RNA and protein to improve resistance against diseases. ViAqua's initial therapeutic utilizes a proprietary double-strand RNA (dsRNA) particle encapsulation that triggers the anti-viral RNAi in shrimp cells to fight and suppress white spot syndrome.
S2G believes the ViAqua team has the potential to apply its technology across all aquaculture species and platforms where cost-effective RNA production and novel delivery systems (such as nano and micro encapsulation) are needed.
